This page shows the latest Pfizer UK news and features for those working in and with pharma, biotech and healthcare.
UK. The study – published on the preprint server bioRxiv – used the blood of 16 participants in Pfizer/BioNTech’s previously reported phase 1/2 trial of BNT162b2 to test for neutralisation ... The study was conducted using blood samples from 20
In December 2020, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) issued guidance warning people with a history of allergic reactions not to get the Pfizer/BioNTech COVID-19 ... vaccine. This guidance followed reports of anaphylaxis
The UK has already approved three COVID-19 vaccines: Pfizer/BioNTech’s mRNA-based vaccine, AstraZeneca(AZ)/Oxford University’s vaccine and most recently Moderna’s vaccine. ... While people in the UK have already been receiving the Pfizer/BioNTech
The UK has already approved three COVID-19 vaccines: Pfizer/BioNTech’s mRNA-based vaccine, AstraZeneca(AZ)/Oxford University’s vaccine and most recently Moderna’s vaccine. ... While people in the UK have already been receiving the Pfizer/BioNTech
The most significant marker of this ‘new era’ for Pfizer is undoubtedly its BioNTech COVID-19 vaccine. ... The UK approved the Pfizer/BioNTech vaccine in December 2020, with over 600, 000 people having received the first dose of the vaccine as of
The AZ/Oxford University COVID-19 vaccine is the second one to be approved in the UK, after Pfizer/BioNTech’s vaccine was authorised in December. ... The Department of Health and Social Care (DHSC) also announced today that over a million people in the
More from news
Approximately 2 fully matching, plus 145 partially matching documents found.
communications. She spent the last decade working as a director of communications for Pfizer, Inc., in New York, the UK and Paris.
Jack Brownrigg, Medical Affairs, Rare Disease, Pfizer UK, told us clinical trials with fewer potential participants required more nuanced trial designs. ... Patient-centricity is also core to Pfizer’s rare disease recruitment strategy, said Brownrigg.
The hearing was more or less unprecedented in terms of a pharma company’s CEO being called on to explain its tactics before UK Parliament – the questioning of Pfizer’s ... These included questions to Jeff Leiden about his salary, the company’s
Pfizer’s UK managing director and newly appointed ABPI President talks to PME about the NHS at 70, the potential of pharma partnerships and some lessons from Europe. ... 10.8% of GDP is spent on healthcare in the Netherlands versus 9.8% in the UK.
Erik Nordkamp, Managing Director of Pfizer UK and the new ABPI President elect (pictured), struck a very different tone, congratulating the NHS and pledging to work closely with the health service. ... care spending in the UK has fallen by 9.9% between
More from intelligence
Approximately 0 fully matching, plus 15 partially matching documents found.
Shafie's previous experience includes roles at the ABPI and Pfizer UK. ... Shafie’s career experience includes time spent as head of government affairs at the ABPI and corporate public affairs lead for Pfizer UK.
Maine, who previously served as head of policy and public affairs at Pfizer UK, was responsible for government affairs and market access policy development activity, covering both corporate and therapy area ... Prior to his time with Pfizer, Maine was
director. Finke brings 15 years industry experience from the likes of Shire and Wyeth (now part of Pfizer) to the Southampton, UK-based agency, having previously worked on market access challenges
Airey (pictured right) becomes venture developer at the biotech, bringing 28 years of healthcare operating experience at firms including Baxter and Pfizer across the UK, Europe and India.
He replaces Jonathan Emms, who is stepping down as president as he is leaving his role as head of Pfizer's UK business to a new role with the company in ... Kearney held UK and international roles at GlaxoSmithKline and international roles at Pfizer,
More from appointments
Approximately 0 fully matching, plus 12 partially matching documents found.
Wilmington Healthcare, which provides data, insight and intelligence for pharma and medtech companies, has appointed Pfizer’s former UK Digital Marketing Manager, Mikko Figura, as Head of Digital. ... Prior to that, he was UK Digital Marketing Manager
Health Products Regulatory Agency’s speedy approval of the Pfizer-BioNTech COVID-19 vaccine in the UK. ... A good example is a recent incident in the UK that made headline news, where two NHS workers who were among the first to receive the
Cannes or Canned? brought together UK and internationally based senior communicators from seven pharmaceutical companies. ... Lilianna Husseini, Director Communications, Oncology, Pfizer Global. Heidi LaPensée, Brand Lead, CNS, Sanofi UK.
More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.
Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and...